Navigation Links
'Bacillus anthracis and Anthrax'
Date:1/12/2011

Few strands of bacteria have achieved such a central place in public consciousness as Bacillus anthracis, the bacteria which causes Anthrax. While today it is a feared weapon of bioterrorism Bacillus anthracis has played a significant historical role, especially through the research of the celebrated 19th century scientists Robert Koch and Louis Pasteur, in shaping our understanding of infectious diseases and immunology

In his new book Bacillus Anthracis and Anthrax Dr Nicholas Bergman brings both of these perspectives together to present a definitive 'state of the field' summary for anthrax research, providing a comprehensive guide to all aspects of the organism, ranging from basic biology to central public health issues.

"With all the attention and research that have been focused on Bacillus anthracis and anthrax in recent years, our understanding of both the organism and the disease has improved dramatically," said Bergman. "This book aims to provide a up-to-date reference that will be useful to scientists, medical and public health personnel, and those playing roles in shaping public policy."

Bacillus Anthracis and Anthrax covers all major aspects of Anthrax biology, from basic biology and pathogenesis to diagnosis, treatment, and prevention of anthrax bioterror-associated issues.

Throughout the book anthrax is considered historically as well biologically, with chapters ranging from the impact of anthrax on human history from 5000 BC by Peter Turnbull and Sean Shadomy, to an assessment of current anthrax vaccination research by Elke Saile and Conrad Quinn, as well as an analysis by Leonard Cole of anthrax as a weapon of war.

The biological analysis of B. anthracis, includes research on life cycle, differentiation, cellular structure, as well as the interaction of B. anthracis with the immune system.

Bacillus Anthracis and Anthrax also considers the clinical features, diagnosis and treatment of the diff
'/>"/>

Contact: Ben Norman
Lifesciencenews@wiley.com
44-012-437-70375
Wiley-Blackwell
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Poll: Hypothetical anthrax attack and antibiotics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... July 30, 2015 , ... 24/7 Care At Home, a high-quality provider ... recently announced that the Centers for Medicare and Medicaid (CMS) have awarded its agency ... providers. 24/7 Care At Home’s agency is one of three top Orange County agencies ...
(Date:7/30/2015)... ... July 30, 2015 , ... Ross A. Clevens, MD, FACS ... as Assistant Professor of Plastic Surgery. This is Dr. Clevens’ second appointment by ... with the university, developing a strong presence and a valuable mentoring program for medical ...
(Date:7/30/2015)... ... July 30, 2015 , ... Western University of Health ... 2015 Special Olympics World Games, the largest sports and humanitarian event in the world ... Games. , The World Games, held July 25 through August 2, 2015, benefited from ...
(Date:7/30/2015)... , ... July 30, 2015 , ... Ocean Hills Recovery ... including the very rare “no recommendations.” No recommendations means CARF found no areas in ... a notation that less than 3% of all facilities receive. In addition, Ocean Hills ...
(Date:7/30/2015)... ... 2015 , ... New research finds some distinct differences in the way mesothelioma ... the Surviving Mesothelioma website. , Researchers with the National Institutes of Health, the ... of mesothelioma occurring between 1990 and 2010. Two percent of these cases (207) occurred ...
Breaking Medicine News(10 mins):Health News:24/7 Care At Home Earns a 5-Star Rating from the Centers for Medicare and Medicaid (CMS) 2Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 2Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 3Health News:WesternU Makes Big Impact at Special Olympics 2Health News:WesternU Makes Big Impact at Special Olympics 3Health News:Ocean Hills Recovery Receives Accreditation from CARF International 2Health News:Study Finds Mesothelioma Behaves Differently in Younger People, According to Surviving Mesothelioma 2
... Women undergoing treatment for breast cancer might fight off ... off the couch. According to the University of ... treatment have less depression and an enhanced quality of ... who are physically active may also have more confidence ...
... Ill. -- Loyola researchers are reporting surprising findings about a ... cases and suppress it in others. The finding eventually ... by, for example, revving it up to attack tumor cells ... organs. The study is published online ahead of print ...
... HealthDay Reporter , FRIDAY, April 13 (HealthDay News) -- Obese ... much more radiation than people of normal weight, researchers say. ... radiation is needed to scan their bodies, a radiation specialist ... patient size, increase the power of the X-rays and the ...
... 13 (HealthDay News) -- Obese workers have even higher health ... data from more than 30,000 Mayo Clinic employees and retirees ... The analysis revealed that both obesity and smoking were associated ... $1,275 more for smokers than nonsmokers and $1,850 more for ...
... By Alan Mozes HealthDay Reporter , THURSDAY, ... Chinese medicines that were seized by Australian customs ... and combinations that could have produced allergic or even ... investigation unearthed evidence that some of the medicines also ...
... News) -- A new study finds that obesity accounts for ... more than twice as high as previous estimates. The ... said the researchers from Cornell University in Ithaca, N.Y. ... $2,741 a year higher (in 2005 dollars) than if they ...
Cached Medicine News:Health News:Discovery could help to develop drugs for organ transplant and cancer patients 2Health News:CT Scans Deliver More Radiation to Obese People: Study 2Health News:DNA Testing Finds Allergens, Toxins in Traditional Chinese Medicines 2Health News:DNA Testing Finds Allergens, Toxins in Traditional Chinese Medicines 3Health News:DNA Testing Finds Allergens, Toxins in Traditional Chinese Medicines 4
(Date:7/30/2015)... 2015  Amgen (NASDAQ: AMGN ) today ... 2015. Key results include: , Total revenues ... 2014 to $5,370 million, with 6 percent product ... (etanercept), Prolia ® (denosumab), Sensipar ® ... (denosumab). Unfavorable changes in foreign exchange rates ...
(Date:7/30/2015)... , July 30, 2015 Tianyin Pharmaceutical Inc. ... company that specializes in the patented biopharmaceutical, modernized traditional ... (API), provided updates regarding the notice it received on ... "Exchange") indicating that the Company was below certain of ... Sections 134 and 1101 of the NYSE MKT Company ...
(Date:7/30/2015)... -- Growth of the U.S. nonprescription market is primarily driven ... to the OTC market. Due to an increasingly favorable ... activity over the next five years with several all ... entering the market into existing categories. If ... those with low to moderate likelihood), the market is ...
Breaking Medicine Technology:Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 2Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 4Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 5Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 6Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 7Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 8Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 9Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 10Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 11Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 12Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 13Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 14Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 15Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 16Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 17Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 18Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 19Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 20Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 21Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 22Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 23TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3
... 9, 2011 Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ... will present a company overview at Barclays Capital,s 2011 Global ... ET at the Loews Miami Hotel. A live ... "Investors & Media" section of the Company,s Web site, ...
... LAKE FOREST, Ill., March 9, 2011 Hospira, Inc. (NYSE: ... pharmaceuticals, today announced U.S. Food and Drug Administration (FDA) approval ... Taxotere®, and Hospira expects to launch the product later this ... of a variety of cancers. In 2010, U.S. sales of ...
Cached Medicine Technology:Hospira Announces U.S. Approval of Generic Docetaxel 2
EL301 Microwell Strip Reader is a portable, rugged, single/dual wavelength photometer designed to measure and interpret the absorbances of microwell strip assays....
Elisa strip reader...
... certified microstrip reader. Stat fax 303 ... to use with step-by-step prompting and ... other programming enhancements. On-board software calculates ... & a variety of cutoff options. ...
... Incubator/Shaker HT is designed for extended ... is ideal for applications such as ... Iems Incubator/Shaker HT is available as ... of three microplates. Iems Incubator/Shaker HT ...
Medicine Products: